Philly Enterprise Tech Daily Roundup 10/31: Foxconn, Honeywell, Biotelemetry, Dell Boomi

Tom Paine

 Subscribe in a reader
Subscribe to Philadelphia Tech News by Email

The Verge suggests that Foxconn may not deliver on what it committed to in Wisconsin, where Governor Walker promised a $3 billion subsidy in return for 13,000 new jobs at a new $10 billion plant.

But Pennsylvania tried, and Foxconn's mixed track record in living up to commitments is well established.

Honeywell completed its spinoff of its home automation tech business, now named Resideo, on Monday. on the NYSE. Honeywell also announced it was moving the headquarters for Resideo to Austin.

Malvern-based BioTelemetry (NASDAQ: BEAT) beat Wall Street expectations for both revenue and earnings . BioTelemetry shares have climbed 70 percent since the beginning of the year. It specializes in wireless cardio monitoring.

After struggling through periods when insurance carriers wouldn't reimburse for its expenses, the former Cardionet has rebounded, further spurred by an agreement last year with Appple to test monitoring heart activity through Apple Watch. BioTelemetry is at a $400 million annual revenue run rate, and its market cap is nearly $2 billion.

Dell Boomi announced that its 'new & improved" Boomi community site is now live.

Built on the Salesforce Community Cloud platform, the new Community will continue to offer Boomi customers all of the helpful content and programs they have come to expect, plus much more, says Boomi.